The Blue Cross and National Veterinary Services (NVS) are celebrating the success of a new initiative to generate additional saleable items for the charity, with the help of vet practices across the UK.
Earlier this year, The Blue Cross teamed up with NVS to launch a campaign to sign up vet practices who use NVS services to encourage their staff and clients to donate bags of unwanted clothes and bric-a-brac for the charity to sell and raise funds. This week saw the arrival of the 5,000th bag of donated items arrive at The Blue Cross warehouse
Jonathan Chambers Blue Cross spokesperson said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. We are overwhelmed at the response so far and looking forward to receiving many more bags of goods in the future. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an amazing £100,000 worth of income towards helping sick and homeless animals in the care of The Blue Cross."
Caitrina Harrison, Sales & Marketing Director for NVS said: "We are delighted to be supporting The Blue Cross with this worthwhile initiative. We have an experienced and flexible logistics team, who have been able to help with the delivery and collection of the clothing bags throughout the UK. We have had excellent feedback from many veterinary practices who have got involved and the requests for clothing bags keep coming in."
Veterinary practices who receive their stock and drugs from NVS that are not yet part of The Blue Cross donation scheme can sign up now by contacting julie.godwin@nvs-ltd.co.uk or Jonathan Chambers at The Blue Cross: trading@bluecross.org.uk.
Vetoquinol has released the second set of results from a survey of over 1000 dog owners which the company says has revealed some surprising findings on owner attitudes to pain and pain relieving medications.1
In particular, Vetoquinol says it thinks veterinary surgeons will be surprised by the depth of feeling expressed by pet owners about the issue, and that there are areas where there is potential for the profession to relate to the concerns of clients and adapt communication accordingly.
The key findings highlight that dog owners are likely to be shocked by a diagnosis of long term painful illness in their pet and are very likely to search for further information on the Internet about the pet's condition. Most dog owners think that NSAIDs are likely to cause side effects, with the perceived risk being much greater than the actual level of risk. The results also indicate that even low levels of risk of side effects may be unacceptable to dog owners.
Mark Leddy, Marketing Manager at Vétoquinol said that the strength of the bond between pet and owner should always be front of mind: "A diagnosis of osteoarthritis, for instance, is such a common one, often being made several times a day, so it is easy to become matter of fact about it; yet for the client that news may actually be quite traumatic and the impact hugely underestimated."
Where clients get their information from is important:
The majority of respondents (95%) felt that treatment of osteoarthritis should be started as soon as signs appear and then long term, either consistently or as needed. However, despite recognising the need for treatment, many expressed concerns about side effects when giving their dog long-term medication, with 77% considering it important or very important to choose a medication with a limited range of side effects.
Vetoquinol says the reality is that one in a thousand pets given an NSAID is likely to experience side effects, which vets may feel is not something owners should worry about unduly. The reality for pet owners is that they perceive the risk to be much greater and if informed of the actual level of risk may still experience a significant level of fear that their pet, with whom they have a special relationship, could be that one in a thousand.
Mark Leddy says that, based on these results, there is great scope for the veterinary team to discuss the level and type of risk entailed in administering medication: "Such an approach will help pet owners make more informed decisions about treatment, allay their concerns and provide them with the support they need at what is probably a very difficult time for them."
1. A survey of 1048 dog owners, carried out by petbuzz, on behalf of Vétoquinol, March 2011
Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
A North Wales-based enviro-tech company called Streetkleen has launched PooPrints, a DNA test used to identify the dogs responsible for leaving faeces in public places, in the UK.
Dogs are first added to the DNA World Pet Registry by taking a cheek swab and sending it for analysis at a cost of £29.95. Local authorities and landowners can then test any stray dog mess they find and see if the culprit is on the database, at a cost of £69.95.
Of course it does beggar the question why pet owners would agree to have their dog added to the database (and pay for it).
Streetkleen believes that new new legislation: The Anti-Social Behaviour, Crime and Policing Act 2014, which gives communities the opportunity to set conditions to help prevent nuisances such as dog fouling, would allow local authorities to require all dogs that use a park, for instance, to be registered.
According to the company, having the PooPrints program operational has led to a drop of 90% in recorded dog fouling incidents in many locations as dog owners realise they can be held accountable.
Streetkleen Managing Director Gary Downie said: "As a dog owner myself the challenge was how do we combine positive dog ownership with access to open spaces whilst ensuring we have accountability to local dog policy? PooPrints is a cost effective, permanent solution to dog fouling that helps ensure that our open spaces are clean, safe and welcoming for dog owners and non-dog owners alike."
As part of its continued support of the 2016 regional events organised by VPMA and SPVS, in partnership with Zoetis, the company is sponsoring the ‘Focus on the Practice Team’ course on Thursday 13 October at Chesford Grange, Warwickshire. Four veterinary professionals will be selected at random to win a place worth £210.
Royal Canin says the day will bring together some of the best experts in leadership, management, employment law and staff training to ensure that practices are ahead of the game when it comes to trained, happy and well managed staff.
The first half of the day will concentrate on the impact front of house employees can have on client communication, whilst the second half will cover HR issues. Guest speakers include Brian Faulkner from The Colourful Consultancy, Nick Steele from Zoetis, Veterinary Mentor, Carolyne Crowe, and Alison Lambert from Onswitch.
To have a go at winning a free place, send an email with your name, job title, the name of your veterinary practice and the reason why you would like to attend to royalcaninvet.gbr@royalcanin.com by Friday 30 September. The company will then select four applicants at random and will inform the winners via email by Friday 7 October.
Places on the course can also be booked by calling 01453 872731 or by visiting www.spvs-vpma-events.co.uk. Focus days cost £175 plus VAT for non-members and £125 plus VAT for VPMA and SPVS members (group/ bulk booking discounts are also available). The cost includes lunch and refreshments.
VetViewer is currently used by over 400 small animal, mixed and equine practices in the UK to track their metrics.
The tool also allows users to run simulations - so for instance if the practice has had to stop offering routine consults, or has a reduced number of vets or RVNS available, they can immediately see the impact on the practice top line.
VetViewer can be used by all practices, independent or corporate, or individual branches. It can track performance for the past 18 months, allowing comparisons to be made with before, during and after the COVID-19 outbreak.
VetViewer Director, Alex Arpino, says the service usually helps practices to thrive but right now offers potential to help them survive: "Many clinics are struggling to know what to do for the best and not knowing the magnitude of the economic impact of their decisions doesn't help.
"Everyone wants to protect their staff but also ensure they have jobs to return to. We can link data from nearly every PMS in the UK to VetViewer and the practice's management team is given access to a portal where they can see the data at a glance. Right now, being able to run simulations is central to current and future planning and could help alleviate stress for many practices managers and owners."
In normal circumstances, VetViewer allows practices to look at their performance over time and the effect of any changes they might make. The company says it can also help practices evaluate where they over and under-perform relative to their region and the UK as a whole.
The data available in VetViewer includes income from food, wormers and flea treatments and other provisions that many practices might find ways to sustain in the coming weeks.
Looking forward to a time when isolation and distancing can be lifted, the tool also shows where there is potential for practices to increase income - whether that's because they are under-charging for consults compared to the regional average, or performing fewer neutering procedures, or under-utilising potential diagnostic or imaging aids.
Such information is likely to be vital to recovery, providing a clear indication of the speed of recovery and the services that are making the biggest contribution to that recovery.
The VetViewer service can be demonstrated remotely by the company's dedicated team of Business Development Managers and the service can be activated at a distance, so practices can set up their account quickly and without any costs, either to set up or maintain.
For more information, visit: www.vetviewer.co.uk / www.veterinaryinsights.com or practice owners or managers can telephone 01403 800135 to make an appointment for an online meeting or to find out more.
The 2009 RCVS Continuing Professional Development Record Cards have been sent to all practising vets and Registered Veterinary Nurses.
Undertaking and recording Continuous Professional Development (CPD) is a mandatory professional requirement for these vets and RVNs. Vets must average at least 35 hours of CPD per year and RVNs 15 hours, although many will do far more.
The RCVS can ask to see CPD records - and they may be checked during practice inspections as part of the Practice Standards Scheme. For newly-qualified veterinary surgeons, completing the Professional Development Phase also fulfils the CPD requirements in their first year of practice.
Jill Nute, President of the RCVS, said: "CPD is about maintaining professional competence. Vets and RVNs are expected to make continuous improvements in their knowledge and skills, which will have benefits for their patients and clients, their own development and the profession at large. Undertaking CPD allows vets and RVNs to demonstrate their commitment to maintaining the highest professional standards."
As professionals, vets and RVNs are expected to evaluate what knowledge and skills they need to develop, and how they will do this. This may include activities such as going to particular case-conferences or asking for some in-house training. Getting together with other practices to organise training sessions or secondments or finding a mentor can also be useful.
Personal study - documented in a learning diary detailing the aims of the study, what was studied and the outcomes, for example, a change made to a practice protocol - can also be used. There is no limit on properly documented study, but vets cannot count more than 10 hours, and veterinary nurses five hours, each year of undocumented study.
All CPD activity should be systematically planned to meet identified professional needs, and clear records must be kept of what has been done.
Further information about CPD requirements for veterinary surgeons and Registered Veterinary Nurses can be found on the back of the CPD Record Card, and at RCVSonline (www.rcvs.org.uk).
From 2 April - 2 May, National Pet Month will be encouraging people to get happy and healthy spending time with their pets, with its theme of 'Happiness is... time with your pet'.
Organisers say that during the month, thousands of people will be celebrating happy times with their pets at hundreds of events up and down the country. While many of these events will raise funds for local animal charities, National Pet Month is not just about fund raising. It is also all about raising awareness of how pets make people's lives happier and healthier, and how they can repay the pets they love by looking after them responsibly.
Veterinary practices can get involved in National Pet Month, and show what they have to offer clients and potential clients. Details of how to join in and become a supporter are on the website http://www.nationalpetmonth.org.uk/.
Last year's National Pet Month was apparently the most successful to date, with a record number of 1200 events and nearly £80,000 raised for at least 30 animal charities.
The 2010 overall best National Pet Month event was held by St Boniface Vets in Crediton, Devon. They participated by visiting local nursery and primary schools teaching children about pet health, and specifically raising awareness of exotic animals as pets. Phil Sketchley, Chairman of NPM said: "The 14 excellent educational visits that St Boniface made to local schools and nurseries were inspirational. They were a fantastic example of the partnerships that can be forged between practices and the community during National Pet Month."
He added: "School visits are one great way for practices to get involved - but there are many more. Our top veterinary practice 2010 event, for example, was held by Mill House Vets in Kings Lynn, and which focussed on educating owners on caring for older pets. National Pet Month is an opportunity to help your clients learn more about responsible pet care so they can enjoy their pets for many years to come."
Kruuse has announced that it is now the exclusive veterinary distributor in the UK, Europe, Australia and New Zealand for Nurtured Pets' Anti-LickStrip pet plaster, a natural hypo-allergenic adhesive plaster that deters licking, biting and chewing.
Anti-LickStrip's plaster is made with active ingredients including cayenne pepper, oregano, lemon powder and peppermint that acts as a deterrent to the animal when sniffed, licked or bitten. The veterinary range of Anti-Lick products will be co-branded under the Kruuse 'Buster' brand as: Buster Anti-LickStrip (sizes: small, medium and large) Buster Anti-LickStrip Pro and Buster Anti-LickStrip Pro C.
Andrew Groom, Managing Director, Kruuse UK Ltd. said: "This agreement further expands Kruuse's small animal product portfolio with its customer in Scandinavia, mainland Europe and the UK; increasing the already extensive range of animal tamper deterrents available to the veterinary practitioner."
Lisa Huntsman, President, Lauren Manufacturing & Nurtured Pets said: "This exciting partnership will further expand our products presence within the veterinary industry expanding our delivery of focused health and wellness products to customers, using Kruuse's strong relationships within veterinary practices."
A new study published this month in the Equine Veterinary Journal (EVJ)1 has concluded that toxins from the seeds of the sycamore tree (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) in Europe.
However, to avoid confusion, the authors of the study point out that the American Sycamore (also just called 'the sycamore' in the USA), is a completely different species: Platanus occidentalis. Furthermore, the sycamore found in the UK is also known as the sycamore maple in other countries.
The new research follows on the heels of a study in the USA earlier this year that linked toxins from the box elder tree (Acer negundo) with Seasonal Pasture Myopathy (SPM), the US equivalent of AM2. The discovery marks an important step for the future prevention of this fatal disease.
Atypical Myopathy is a highly fatal muscle disease in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed. SPM is a very similar disorder, prevalent in Midwestern USA and Eastern Canada that is now known to be caused by the ingestion of hypoglycin A, contained in seeds from the box elder tree.
The new European research1 was conducted by an international team led by Dominic Votion, University of Liege and involved 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. High concentrations of a toxic metabolite of hypoglycin A, were identified in the serum of all of the horses. The pastures of 12 of the horses were visited by experienced botanists and the Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
Hypoglycin-A is found in various levels in the seeds of plants in the genus Acer as well as in various other genera in the family Sapindaceae such as ackee (Blighia sapida). In ackee, hypoglycin-A levels do vary with ripeness of the fruit and, if the fruit is eaten before it is mature, it causes hypoglycaemia to different degrees including a condition called "Jamaican vomiting sickness" (because of ackee's use in Jamaican cooking) and occasionally death in humans.
Researchers at the Universities of Minnesota2 and Liege are continuing their work to try to uncover exactly how the equine disease occurs. Dr Adrian Hegeman of University of Minnesota said: "It is likely that the most important contributing factors to horses becoming poisoned by hypoglycin-A are the availability of seed in the field combined with lack of other feeding options. The seeds from two species of maples (box elder and sycamore maples) that we have tested include significant quantities of hypoglycin-A.
"We know that seeds contain highly variable quantities from seed to seed, even within a single tree. We do not know yet how hypoglycin-A levels vary seasonally, nor do we know how its abundance varies with different levels of stress to the plant, though this may well explain seasonal variability in the occurrence of the malady. It is possible that conditions that stress the plants may contribute to significant seasonal changes in hypoglycin-A levels. At this point we just don't know. It is common held knowledge that trees under stress usually produce more seed."
Dr Jeff Gillman of University of Minnesota said: "Without question, further analysis of the seeds and other tissues from Acer species needs to be performed along with sampling of plant materials over multiple seasons and at various stress levels. Additionally, one cannot rule out more complex explanations for the seasonality of disease occurrence such as: animals may begin feeding on seed materials in response to depletion of more palatable choices under drought conditions; or simple explanations such as high wind events driving seeds into fields. These sorts of explanations for the occurrence of the disease do not depend on botanical variations in toxicity across seasons, sites or stress levels, yet also require consideration.
"Although limited examples are available, the experience of animals at a pasture site might also confer some degree of behavioral resistance to poisoning due to exposure at sub-lethal levels with prior exposure to seeds in the pasture."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is an important advancement in our understanding of what causes AM and how it can be prevented. In immediate practical terms owners can take prompt measures to avoid exposing their horses to sycamore seeds this autumn. Where horses are grazing in the vicinity of sycamore trees, it is imperative that they are provided with sufficient supplementary feed as this will minimise the risk that horses might be tempted to ingest seeds containing this toxin. This must be done carefully and leaving wet hay on the ground should be avoided so providing extra carbohydrate feeds may be more practical."
References
Elanco Animal Health has launched an updated Atopica Comfort Club, a support initiative for veterinary professionals treating either canine atopic dermatitis or feline allergic dermatitis cases with Atopica.
The Atopica Comfort Club loyalty scheme now has a new website which enables all members of the practice team to see the cases being managed and the offers available for new and existing users post diagnosis. The initiative provides veterinary practices with a free of charge Atopica redemption scheme through both induction and maintenance periods.
Elanco says the new website will also enable veterinary practices to view and redeem offers instantly, receive reminders about offers and updates together with emails to confirm offers have been redeemed and the products despatched.
Alice Laurens, DVM MRCVS, Dermatology Marketing Manager at Elanco Animal Health, said: “The Comfort Club loyalty scheme embraces a multi-modal approach and ensures better comfort is provided to Atopica patients with options to offer a flea product, shampoo, essential fatty acids and an adapted diet.”
To support the new Atopica Comfort Club loyalty program, Elanco has also produced a ‘practice log book’ to enable vets to record details on each case which can then be entered onto the Comfort Club website.
For further information, or to book a lunch and learn meeting, please contact your local Elanco Animal Health key account manager or email elancoCAH.uk@elanco.com.
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
The survey, which is being conducted in partnership with Hazlewoods accountants, will be used to provide anonymised benchmarking information to enable vets to compare their practice profitability and help identify areas where profitability could be improved.
The survey asks questions around a range of reporting figures including gross profit margin, staffing cost levels and EBITDA (Earnings before interest, taxes, depreciation, and amortisation), to allow for benchmarking in greater detail.
The anonymised benchmarking results of the survey will be free to all participants, including non SPVS members.
SPVS members will receive the benchmarking results together with supporting commentary.
The deadline for completion is 4th November 2022.
https://spvs.org.uk/spvs-profitability-survey
The British Veterinary Association has given a cautious welcome to the merger of the Animal Health Agency (AH) and the Veterinary Laboratories Agency (VLA) announced yesterday by Secretary of State Caroline Spelman.
Professor Bill Reilly, President of the BVA said: "On the face of it there could be significant benefits in merging these two key animal health organisations. Already, at local and national levels, the two agencies are required to work closely and if done properly we could have one body that is completed committed to animal health.
"However, every veterinary surgeon will want reassurance that the merger will not simply become another way to cut costs by reducing the number of people working on disease surveillance and research. It is vital that both organisations continue to deliver under the new body.
"The merger could have an impact on responsibility and cost sharing plans, the tendering exercise for Official Veterinarian (OV) work, and the future of animal health delivery in the devolved administrations. The BVA is therefore calling for a wide consultation on how the merged organisation will work to ensure the best for the veterinary profession, farming community and all other interested organisations."
The new reader is compatible with all ISO 15-digit (FDX-B) identification microchips. It features an integrated LCD screen that displays microchip numbers in a large, easy-to-read format and it also reports the temperature of temperature-sensing microchips.
Sureflap says the reader is lightweight, ergonomically designed, fits easily into the hand and is easy to operate. The company also says that its small size makes it less intimidating for pets.
Dr Nick Hill, managing director of SureFlap said: "The SureSense Microchip Reader was developed following feedback from veterinary and shelter staff that they often had to share microchip readers.
"The reader is our first professional product, developed exclusively for veterinary professionals, shelters, breeders and pet care professionals. Its affordability and size will ensure that it is possible to have multiple readers in each veterinary practice and shelter."
For further information, contact your wholesaler or the SureFlap team on 0800 9127 114 or via email vet@sureflap.com.
RCVS Knowledge says it first identified the need for an open access and easily accessible means of distributing veterinary evidence in early 2014. The concept for a new digital journal was announced at the 2014 EBVM Network Conference, and began with the mission statement of improving front-line clinical standards, funded initially by a donation from the RCVS.
In its first year Veterinary Evidence has published 58 papers which have been downloaded over 34,000 times by an international audience spanning 20 countries. It has also streamlined its submission process and added a range of new tools and resources. The tools include a downloadable submission template and a range of checklists and guidelines to help the practitioner conduct evidence-based medicine.
Looking to the future, the charity says that its website platform will be overhauled later in 2017, so practitioners can find articles quickly and implement their findings in practice.
RCVS Knowledge is now running a survey to find out what topics you'd like to see covered by Veterinary Evidence. All participants will entered into a draw for a new iPad.
Veterinary Evidence is also on the hunt for a new Editor-in-Chief, to move the journal into its next chapter. The Editor-in-Chief will have a passion for EBVM and engaging with the veterinary community and will help provide readers with the content they need. If you’re interested in applying for this role you can view the full job description here.
In the study titled “Evaluation of urethral orifice cross-section dimensions following perineal urethrostomy in male cats”, 24 male cats with lower urinary tract disease underwent the procedure. The urethral orifice cross-section was estimated by the largest urinary catheter that could be easily inserted through the stoma at three time points: preoperatively, intra-operatively and 12 days postoperatively. Cases of obstruction recurrence and stricture were documented within the six month follow up period.
Uri Segal, corresponding author for the paper, said: “The intraoperative stoma ranged from 1 to 10 (median 10) Fr and the 12-day postoperative stoma ranged from 4 to 10 (median 8) Fr. There was significant reduction of stoma size 12 days postoperatively, compared to the measurements taken intraoperatively.
"Postsurgical stricture formation and re-obstruction was documented in five of 24 (21%) of cats. Obstruction recurrence is probable if the intra-operative stoma size is 8 Fr or less. Furthermore, if the stoma size is 6 Fr or less, re-obstruction is almost certain (all of these cases in the study were re-obstructions). Conversely, an intra-operative stoma of more than 8Fr had a low risk of recurrence.”
Nicola Di Girolamo, editor of JSAP said: “These findings may function as a guiding rule for surgeons performing perineal urethrostomy, by providing an intraoperative measure of how likely re-obstruction and stricture formation is to occur. It should be remembered, however, that the functional urethral stoma cross-section may vary during the urination cycle and the measurements in this study are likely to only represent a fraction of the functional urethral cross-section size.”
The full article can be found in the August issue of the Journal of Small Animal Practice. It can also be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13148
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Parasitologists from ESCCAP (European Scientific Counsel Companion Animal Parasites) have been voicing their concern over the implications of the imminent changes to the UK's DEFRA-run Pet Travel Scheme (PETS).
Under the new regulations, which take effect from Jan 2012, tick control will no longer be mandatory. According to ESCCAP, a recent study has demonstrated that a population of exotic tick species has already become established in the south-east of England1. With up to 15,000 animals travelling under PETS each month, the possibility of exotic ticks (and their associated tick-borne diseases) entering and establishing in the UK becomes increasingly likely. The European Parliament has yet to rule on mandatory tapeworm control. The decision will impact on the future distribution of, and disease threat from, Echinococcus multilocularis.
ESCCAP UK is advising all veterinary surgeons to discuss the risks with their clients and to ensure they make an informed decision about tick control when the new legislation comes into effect.
In addition, the UK branch of ESCCAP is holding a free seminar in Bristol on 28th October to highlight the role that veterinary practices can play in helping clients understand how the changes could impact upon their pet's health.
ESCCAP says the seminar will provide all the information clinicians need to have an informed dialogue with clients. Presentations will provide an overview of the impact of the changes to PETS in relation to rabies, Echinococcus and ticks, as well as advice about how to communicate the information to pet owners and the tools and support available.
Additional support includes ESCCAP UK's website http://www.esccapuk.org.uk/, which offers updates on the PETS situation, guidelines for parasite control programmes and podcasts for veterinary surgeons, nurses and pet owners.
The seminar takes place at Engineers' House, The Promenade, Clifton Down, Bristol BS8 3NB.
To register, telephone: 01684 568998, or email: info@esccapuk.org.uk
Reference1. Smith F D, Ballantyne R, Morgan E R, Wall R (2011) Prevalence, distribution and risk associated with tick infestation of dogs in Great Britain. Medical and Veterinary Entomology. doi: 10.1111/j.1365-2915.2011.00954.x
The survey for vets is about two minutes long: www.smartsurvey.co.uk/s/ZCONJA/.
A prize draw will be carried out after the survey closes with 10 participants winning a Q fever snood.
Renzo Di Florio, veterinary advisor at Ceva Animal Health, said: “Despite Q fever being endemic in GB dairy herds1, we believe that awareness amongst farmers and the related farming industries is low.
"Our national Q fever surveys will help us ascertain how we can support farmers and vets when it comes to diagnostic challenges, treatment options and prevention through vaccination to help protect farmers, farming families and the related professions from the disease and reduce the impact of Q fever on farms.”
Jonathan Statham MA VetMB DCHP FRCVS, a RCVS registered specialist in cattle health, co-author of the ‘Dairy Herd Health’ textbook and chief executive of RAFT Solutions, added: “Multiple surveys in the UK support Q fever prevalence ranging from 60 to 80% in our national dairy herd, including recent work carried out by RAFT Solutions in NE England and SW England (2021)2.
"Reproductive issues are of course multifactorial and it is important therefore not to associate a Q fever positive diagnostic result as a single cause of infertility.
"However, increased level of metritis and endometritis, abortion and pregnancy loss or extended calving-conception intervals merit further investigation with Q fever as part of a herd health discussion that should of course address other infectious disease such as BVD, IBR or leptospirosis.
"Q fever is of further significance as a zoonosis and also as a potentially emerging disease in the context of climate change and changing vector patterns.”
Ceva has also launched a social media toolkit containing social media graphics and content on the disease that can be posted on vet practice social media channels, available from your local Ceva account manager.
The RCVS ERP provides an ethics review mechanism for researchers who are based in practice and don't have access to this process through university and industry connections.
The subcommittee has representation across a range of areas of veterinary expertise, including veterinary nursing, and also includes lay researchers and scientists.
Since its formation as a trial service in 2016, the ERP has reviewed more than 530 research proposals on behalf of the College.
Nicola said: “I am honoured to be offered this position.
"Having been a member of RCVS ERP for the past three years and undertaking a similar role as the Chair of the Clinical Research Ethical Review Board at the Royal Veterinary College, I felt that I had the right expertise to take on the role
“It is vitally important that all research, regardless of where it is undertaken, undergoes ethical review to ensure that robust results are produced especially when they have the potential to influence clinical practice, and so I really welcome the work the ERP has been undertaking.
“As chair of the ERP I hope to build on the success of my predecessor and continue to support those working in clinical practice that is not associated with a university to undertake valuable research and add to the body of evidence that supports our clinical decision-making.”
www.rcvs.org.uk/ethics
The association says that its research has found that 94% of companion animal vets say they have clients who feed a raw diet, 42% who feed meat-free diets and 29% who feed insect-protein in place of meat.
However, 6 in 10 vets are unsure how many of the cats and dogs they see are fed meat-free diets.
In a new policy position, the BVA is now urging vets to talk to all cat and dog owners about what they feed their pet, and record nutritional histories and any resulting issues on their practice systems.
BVA President Anna Judson said: “We know that owners of cats and dogs are increasingly drawn to pet diets that reflect their own personal values and lifestyle choices, and this is leading to a surge in alternative approaches to pet food.
"We support owners making informed choices about what to feed their pets, but they must be aware that these choices play a pivotal role in the health of the animal and can also have a wider impact on human health and environmental sustainability.
“One of the key issues in these conversations is the lack of long-term, evidence-based research.
"If vet teams are to maintain our position as the ‘trusted voice’ in these conversations, it’s vital that we ask the right questions and also record as much data as possible so that we can understand the long-term impact of some of these newer diets.”
The BVA says its new policy position is not trying to dictate the ‘best’ diet for individual pets but to support pet owners in meeting their pets’ nutritional needs as well as meeting their own lifestyle choices.
The BVA is also recommending changes to veterinary education to include a new emphasis on the importance of nutrition in day one competencies for vets and nurses, and improved awareness of the need for supportive conversations with animal owners.
To support the profession, the BVA says it will create a new public facing resource and lobby for better labelling of pet food and better labelling and traceability of the animal by-products that represent one of the major sources of protein in many cat and dog foods.
Anna added: “The issues around pet food are complex and with so much information available to pet owners from breeders, friends, online forums and other sources, we want to support all members of the vet team to feel fully confident in guiding their clients through dietary decisions.
"We hope that these recommendations and our upcoming resources will improve the information available to both clients and vets, supporting owners to make healthy, informed choices for their pets.”
https://www.bva.co.uk/take-action/our-policies/diet-choices-for-cats-and-dogs
The company is now asking farm vets to point their clients in the direction of the FarmComm study and encourage them to take part, share their thoughts and help shape the way we all work together in the future.
Mat Yarnall, senior brand manager at Boehringer said: "With routine visits, practice meetings, herd or flock health planning sessions and farming shows and exhibitions all on-hold, how vets work with their clients is subject to change on a scale never seen before.
“The study is striving to understand what methods of working going forward may work, what won’t work and how people want to work.”
The FarmComm study will be being sent out directly to farmers or can be accessed at https://bit.ly/farm-comm.
Matt added: "Following analysis and interpretation, these findings will be shared with vets as we all move together into new and different times."
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.